Axsome Therapeutics, Inc. (LON:0HKF)
London flag London · Delayed Price · Currency is GBP · Price in USD
160.18
-2.17 (-1.34%)
Mar 6, 2026, 3:54 PM GMT

Axsome Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
322.93315.35386.19200.8486.47
Cash & Short-Term Investments
322.93315.35386.19200.8486.47
Cash Growth
2.40%-18.34%92.29%132.26%-52.97%
Accounts Receivable
224.4614294.8237.7-
Inventory
27.9415.7315.144.32-
Other Current Assets
13.6511.988.122.780.05
Total Current Assets
588.99485.06504.26245.6486.52
Net Property, Plant & Equipment
21.425.977.621.140.94
Other Intangible Assets
40.5246.8953.2959.66-
Goodwill
12.0412.0412.0410.31-
Other Long-Term Assets
26.8418.5311.0314.720.32
Total Assets
689.81568.5588.24331.4887.79
Accounts Payable
65.547240.6838.6113.15
Accrued Expenses
232.85147.9990.551.639.3
Short-Term Debt
70----
Current Portion of Leases
0.431.841.270.430.62
Other Current Liabilities
10.018.296.415.9-
Total Current Liabilities
378.84230.1138.8596.5623.07
Long-Term Debt
117.75180.71178.0794.2649.09
Long-Term Leases
27.398.997.04--
Other Long-Term Liabilities
77.5491.6873.331.1-
Total Long-Term Liabilities
222.67281.38258.41125.3649.09
Total Liabilities
601.51511.48397.26221.9272.15
Common Stock
0.010.010.0100
Additional Paid-in Capital
1,3941,1801,027705.89424.83
Retained Earnings
-1,306-1,123-835.57-596.33-409.2
Shareholders' Equity
88.357.02190.98109.5615.63
Total Liabilities & Equity
689.81568.5588.24331.4887.79
Total Debt
215.57191.53186.3794.6849.71
Net Cash (Debt)
107.37123.82199.82106.1636.76
Net Cash Growth
-13.29%-38.04%88.23%188.77%-72.51%
Net Cash Per Share
2.162.584.402.610.98
Book Value
88.357.02190.98109.5615.63
Book Value Per Share
1.771.194.202.690.42
Tangible Book Value
35.73-1.92125.6539.5915.63
Tangible Book Value Per Share
0.72-0.042.770.970.42
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.